Found 11 articles for: "medication"
Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review
September 2026 | Volume 25 | Issue 9 | Original Article | 821 | Copyright © September 2026
Background: Acne vulgaris is a common dermatologic condition often requiring treatment using multiple mechanisms of action over a long time course to adequately clear symptoms. H...
Read MoreGLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity
August 2026 | Volume 25 | Issue 8 | Features | 753 | Copyright © August 2026
FDA Boxed Warnings: Should Package Inserts Include Levels of Evidence?
December 2025 | Volume 24 | Issue 12 | Features | e67 | Copyright © December 2025
Many medications commonly used in dermatology come with package inserts that contain boxed warnings that are frequently not evidence-based. Boxed warnings are the most serious warnings that the U...
Read MoreExploring the Gut Microbiome's Role in Drug-Induced Photosensitivity: A Need for Deeper Investigation
June 2025 | Volume 24 | Issue 6 | Editorials | e40 | Copyright © June 2025
Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report
June 2025 | Volume 24 | Issue 6 | Case Reports | 636 | Copyright © June 2025
Calcitonin gene-related peptide (CGRP) is a neuropeptide involved in neurogenic inflammation and vasodilation, playing a key role in the pathophysiology of both migraines and inflammatory skin co...
Read MoreIs Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis
May 2025 | Volume 24 | Issue 5 | Original Article | 530 | Copyright © May 2025
Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition associated with risk of cardiovascular disease (CVD), potentially mediated by persistent systemic infl...
Read MoreDo the Words We Choose Matter When Prescribing Medications?
December 2023 | Volume 22 | Issue 12 | Original Article | 1216 | Copyright © December 2023
Background: Caregivers are often apprehensive about treating childhood atopic dermatitis (AD) with topical corticosteroids but may find comfort if treatments are presented in a p...
Read MoreThe Potential Impact of Off-Label Medication Use on Patient Access: A Cross-Sectional Survey of Minoxidil Availability
January 2024 | Volume 23 | Issue 1 | Editorials | 1360 | Copyright © January 2024
Treatment and Maintenance of Cutaneous Rosacea in Latino Skin Types With Prescription Medications and Non-Prescription Cleansers and Moisturizers as Adjuncts: A Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1111 | Copyright © October 2022
Background: Rosacea is an inflammatory dermatosis with at least a ten percent prevalence reported among white adults. Rosacea occurs in nonwhite populations, but prevalence data is li...
Read MoreSystemic Medications Associated With Hair Texture Changes
September 2022 | Volume 21 | Issue 9 | Original Article | 989 | Copyright © September 2022
Background: In addition to hair loss, alterations in hair texture can be a worrisome side effect of certain medications yet are seldom reported and poorly characterized.
Adherence and Persistence to Acne Medications: A Population-Based Claims Database Analysis
July 2022 | Volume 21 | Issue 7 | Original Article | 758 | Copyright © July 2022
Background: The chronicity of acne and its treatment with topicals contribute to poor treatment adherence and persistence. How well newly diagnosed acne patients use their treatment i...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
